FIELD OF INVENTIONThe present invention relates to a system comprising an energy delivery device.
BACKGROUNDEnergy delivery devices (e.g., antennas, probes, electrodes, etc.) (e.g., microwave ablation devices) (e.g., radiofrequency ablation devices) are used to deliver energy to a desired tissue region for purposes of "treating" a desired tissue region. Ablation therapy (e.g., microwave ablation, radiofrequency ablation) is a widely used, minimally invasive technique for the treatment of various conditions and/or disorders (e.g., tumor cells). Within such techniques, ablation energy (e.g., microwave energy) (e.g., radiofrequency energy) is used to heat a desired tissue region to a desired temperature to cause tissue destruction in the heated region.
The success of an ablation procedure is generally dependent upon maximizing the amount of desired tissue ablation and minimizing the amount of undesired tissue ablation. Such success is dependent upon the precise and accurate identification of a targeted tissue region, positioning of the energy delivery device at such an identified targeted tissue region, and delivery of such energy to the identified tissue region.
Improved techniques for accurately and precisely identifying a targeted tissue region targeted for an ablation procedure are needed.
Current techniques for identifying a targeted tissue region for an ablation procedure involve, for example, use of CT imaging or other imaging modalities. For example, CT imaging is used to locate and identify the specific anatomical region (e.g., three-dimensional anatomical dimension) to be ablated and based on that identified location, positioning of an energy delivery device at that identified location, and delivering ablation energy to the identified location.
A problem that limits the success for the ablation procedure, however, involves anatomical changes a targeted tissue region undergoes while being ablated. Indeed, the anatomical dimension of a tissue region undergoing an ablation procedure changes as the tissue region is ablated. For example, the anatomical dimension of a tissue region undergoes contraction during ablation which changes the pre and post procedure anatomical dimensions of the tissue region. Such anatomical changes that occur during the procedure (e.g., contraction) result in exposure of undesired tissue (e.g., healthy tissue) to the ablation energy. Such undesired ablation of non-targeted tissue not only compromises the success of the ablation procedure, but can result in serious adverse health consequences, particularly if the ablation zone is near healthy critical tissues or structures. If one attempts to compensate by selecting a smaller zone, one risks not destroying all of the intended tissue, which may make the treatment less efficacious, or in the case of tumor ablation, allow for tumor regrowth and metastasis.
The current techniques used to locate and identify the specific anatomical region (e.g., three-dimensional anatomical dimension) to be ablated (e.g., CT scan) fail to accommodate such anatomical changes (e.g., tissue contraction) as a targeted tissue region undergoes an ablation procedure.
US 2009/196480 A1 describes a thermal ablation system that is operable to perform thermal ablation using an x-ray system to measure temperature changes throughout a volume of interest in a patient. Image data sets captured by the x-ray system during a thermal ablation procedure provide temperature change information for the volume being subjected to the thermal ablation. Intermediate image data sets captured during the thermal ablation procedure may be fed into a system controller, which may modify or update a thermal ablation plan to achieve volume coagulation necrosis targets. The thermal ablation may be delivered by a variety of ablation modes including radiofrequency ablation, microwave therapy, high intensity focused ultrasound, laser ablation, and other interstitial heat delivery methods. Methods of performing thermal ablation using x-ray system temperature measurements as a feedback source are also provided. Methods of assessing the post-ablation status of the patient and performance of the system are also provided.
US 2013/259335 A1 describes a method that includes obtaining first volumetric image data, which is acquired at a first time, including a region of interest with a structural feature located at a first position. The method further includes obtaining second volumetric image data, which is acquired at a second different time, including the region of interest with the structural feature located at a second different position. The method further includes determining a registration transformation that registers the first and second volumetric image data such that the at least one structural feature in the first volumetric image data aligns with the at least one structural feature in the second volumetric image data. The registration transformation is based at least on a contour guided deformation registration. The method further includes generating a signal indicative of the registration transformation.
US 2007/230757 A1 describes an imaging and diagnostic system and method that are used for differentiating between malignant and non-malignant tissue of a prostate and surrounding region. The imaging device of the system acquires imaging data from the prostate and surrounding proximal region, processes the data to differentiate areas of tissue malignancy from non-malignant tissue. A sectioning device or ablative device is provided. The ablative device is operable by automation for receiving the imaging output coordinates and defining the trajectory and quantity of energy or power to be delivered into the malignant tissue of the prostate region. A control system determines calculated energy or power to be deposited into the malignant tissue during ablation, to minimize destruction of the non-malignant tissue within the prostate and surrounding tissue. The system operates on generated ablative device output data. The energy device output data can guide the position or orientation of the delivery device or guides the delivery of energy or power from the ablative device into the malignant prostate tissue under active surveillance of the imaging device of the system. Destruction of the target tumor is thus monitored and controlled by active imaging.
US 2009/281536 A1 describes medical devices for diagnosing and treating anomalous tissue and methods of use. The medical device can comprise an energy source configured to emit at least an excitation beam and a therapeutic beam, a probe coupled to the energy source and configured to propagate the excitation and therapeutic beams with the beams capable of contact with the tissue, a sensor coupled to the probe that detects at least one predefined attribute of radiation emanating from the tissue when the tissue is subjected to the excitation beam and a controller coupled to the energy source and the sensor and programmed to selectively alternatively actuate the energy source to emit the excitation beam and the therapeutic beam in response to the detection of the at least one predefined attribute by the sensor.
Summary of the InventionAccording to an aspect of the invention, there is provided a system, comprising:
- an energy delivery device; and
- a processor configured to identify a target tissue region adjusted for expected ablation-related anatomical changes including tissue contraction during ablation by:receiving information regarding the tissue region and the energy delivery device;based on said information, performing computations to predict the amount and type of anatomical changes the target tissue region will undergo during ablation, said computations including the following steps:computing a contraction region within the tissue region;determining contraction points within the tissue region;computing contraction deformations within the tissue region;applying the computed contraction deformations, andidentifying the target tissue region that accommodates said anatomical changes.
Embodiments of this invention can allow delivery of energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). Embodiments of this invention can allow identification and treatment of a target tissue region adjusting for ablation-related anatomical changes (e.g., tissue contraction).
Embodiments of this invention can permit identification and location of a targeted tissue region that accommodates such anatomical changes (e.g., tissue contraction) as a targeted tissue region undergoes an ablation procedure.
The processor may configured to select, and/or modify the target tissue region, adjusting for ablation-related anatomical changes.
In some embodiments, determining the contraction points comprises determining expected contraction points within the tissue region. In some embodiments, computing contraction deformations comprises computing expected contraction deformations within the tissue region (e.g., determining the expected contraction distances (e.g., largest and smallest) and directions for each contraction point). In some embodiments, the computed expected contraction deformations can be applied. In some embodiments, the target tissue region adjusted for ablation-related anatomical changes can be reported.
In some embodiments, the processor is in communication with the energy delivery device. In some embodiments, the processor is configured to position the energy delivery device at a desired tissue region and/or to control energy delivery during an ablation procedure. In some embodiments, the desired tissue region is the identified target tissue region adjusted for ablation-related anatomical changes.
In some embodiments, the processor provides information regarding the contraction points to a user (e.g., via a processor based visual display; via wireless communication, etc.). For example, in some embodiments, the tissue region is provided along with the contraction points and the computed contraction point distances and directions for each point during the procedure (e.g., prior, after, and at any point during the procedure). In some embodiments, the minimum and maximum margin distances for the tissue region and each contraction point is provided.
In certain embodiments, the processor is configured to measure the smallest and largest distance between the target tissue region before and after ablation (e.g., ablation after contraction). In some embodiments, such measured distances are used to determine if desired margins are met during and following an ablation procedure.
In some embodiments, the processor is configured to quantify and compare the distance difference and/or direction difference between a targeted tissue region prior to adjustment for ablation-related anatomical changes and a targeted tissue region prior to adjustment for ablation-related anatomical changes. In some embodiments, the processor is configured to quantify and compare the actual distance difference and/or direction difference (e.g., prior to ablation procedure and post ablation procedure) between a targeted tissue region not adjusted for ablation-related anatomical changes and a targeted tissue region adjusted for ablation-related anatomical changes.
In certain embodiments, the processor is configured to monitor and/or control and/or provide feedback concerning one or more aspects during the ablation procedure. For example, in some embodiments, the processor is configured to monitor the predicted contraction point distance and direction for each contraction point during the ablation procedure. In some embodiments, the processor is configured to stop the ablation procedure if the predicted contraction point distance and/or direction for one or more contraction points is inconsistent with the actual respective contraction point distance and/or direction. In some embodiments, the processor is configured to adjust the amount of energy delivered (e.g., raise or lower) during the ablation procedure if the predicted contraction point distance and/or direction for one or more contraction points is inconsistent with the actual respective contraction point distance and/or direction. In some embodiments, the processor is configured to re-calculate contraction point distances and/or directions for one or more contraction points if the predicted contraction point distance and/or direction for one or more contraction points is inconsistent with the actual respective contraction point distance and/or direction. In some embodiments, the processor is configured to identify new contraction point and/or re-calculate contraction point distances and/or directions for one or more existing contraction points if the predicted contraction point distance and/or direction for one or more contraction points is inconsistent with the actual contraction point distance and/or direction for each contraction point. In some embodiments, processor is configured to make similar adjustments based upon differences in predicted versus actual temperature differences within the tissue region, predicted versus actual temperature differences in the energy delivery device, etc.
In some embodiments, the systems further comprise a power supply electrically connected to the energy delivery device.
A method for ablating a tissue region is described, which comprises providing such a system, identifying a target tissue region adjusted for ablation-related anatomical changes with the processor, positioning the energy delivery device at the identified targeted tissue region adjusted for ablation-related anatomical changes, and ablating the tissue region (e.g., and not ablating tissue outside of the target tissue region). The target tissue region may be identified and/or modified during an ablation procedure.
The tissue region may be within a subject (e.g., a human subject).
The tissue region ablated may not include tissue not included in the identified target tissue region adjusted for ablation-related anatomical changes.
BRIEF DESCRIPTON OF THE DRAWINGSFIG. 1 shows a schematic of an exemplary process used for generating a target tissue region adjusting for ablation-related anatomical changes (e.g., tissue contraction).
DETAILED DESCRIPTIONCurrent techniques used to locate and identify a specific anatomical region (e.g., three-dimensional anatomical dimension) to be ablated (e.g., via CT scan) fail to accommodate for anatomical changes (e.g., tissue contraction) as a target tissue region undergoes an ablation procedure. Such anatomical changes result in undesired ablation of healthy tissue or otherwise cause over- or under-ablation of tissues, inconsistent with the goals of the procedure
The present invention provides system that permit identification, location, and ablation of a target tissue regions that accommodate such anatomical changes (e.g., tissue contraction) as a target tissue region undergoes an ablation procedure.
In some embodiments, a processor (e.g., computer) is used to identify and locate a target tissue region or regions from tissue imaging data that accommodate such anatomical changes (e.g., tissue contraction). In some embodiments, the processor uses software that assesses the presence and absence of variables associated with the tissue region to be ablated and variables associated with the type of energy delivery device and energy to be used during the procedure.
Examples of such variables associated with the tissue region to be ablated and variables associated with the type of energy delivery device and energy to be used during the procedure include, but are not limited to, the type of energy to be utilized during the procedure (e.g., microwave or radiofrequency, or both), the length of time for the procedure, the range of temperatures to be achieved during the procedure (e.g., temperature(s) at the tissue), the type of tissue region undergoing the procedure (e.g., liver, lung, heart, kidney, solid tumor, etc.), the temperature of the tissue region, the age of the subject, the overall health of the subject, etc.
In some embodiments, identification of a target tissue region involves computations based upon the input variables (e.g., variables associated with the tissue region to be ablated and variables associated with the type of energy delivery device and energy to be used during the procedure).
In some embodiments, such computations predict the amount and type of anatomical change the desired tissue region will undergo during a procedure based upon the inputted variable information.
In some embodiments, such computations involve determining contraction points, computing a contraction region, computing contraction deformations, applying such contraction deformations, and generating a target tissue region adjusting for ablation-related anatomical changes (e.g., tissue contraction).
Such assessments are not limited to a particular manner of determining contraction points and computing a contraction region. The contraction points can be determined through computing an approximation of the total extent of the tissue region (e.g., organ tissue) which is contracted during the ablation procedure. The approximation may be morphological or based on the type of tissue and nearby structures. The contraction region can be computed through utilizing the knowledge that at a point of contraction the tissue will contract the most and will reduce as a function of distance and direction from that point. One or more points of contraction can be computed within the ablated area. The computation may be based on geometry of the ablated area or the positioning of the ablation probes.
The knowledge that, due to the nature of the contraction, every location within the contraction region(s) is transformed to some degree, and that the amount of the transformation is a function of the distance and direction from a contraction point can be utilized. In some embodiments, a computed contraction deformation could include a set distance and direction or could include multiple distances for multiple direction changes. The function may be geometric, based on the distance and direction from a contraction point, or physical, based on characteristics of the tissues at that location and structures in the region. In some embodiments, the actual contraction distance is predicted for each contraction point pre-ablation and post-ablation. In some embodiments, the actual contraction direction (including potentially multiple direction changes) is predicted for each contraction point pre-ablation and post-ablation. In some embodiments, both the actual contraction distance and direction (including potentially multiple direction changes) is predicted for each contraction point pre-ablation and post-ablation. For example, for a certain contraction point, the amount of contraction distance and direction (including potentially multiple direction changes) is measured. In some embodiments, the processor is configured to compare the predicted contraction distance and direction and the actual contraction distance and direction for each contraction point.
Those transformations may be described as deformations stored in a deformation grid. The deformation at each location may be described as a vector whose magnitude and direction describe the characteristics of the contraction. For example, in some embodiments, each element of the deformation grid may be defined by a vector which points in the direction of the contraction point and its magnitude may be defined as a linear function of the distance from the contraction point.
The characteristics of the contraction, as described by the deformations, can be applied to the tissue region to be ablated. At each location within the ablation region, upon determination that it intersects the target, the amount of transformation from the deformation grid at that corresponding location is determined. In some embodiments, if the target does not intersect the ablation region, the magnitude of the transformation is applied a value (e.g., zero). In some embodiments, the dimensions of the tissue region to be ablated are adjusted based upon such adjustments (e.g., the tissue region is transformed to the new location based on the direction and magnitude of the transformation).
FIG. 1 shows a schematic of an example of the generation of a target tissue region, adjusting for ablation-related anatomical changes (e.g., tissue contraction). As can be seen, the storage device (e.g., computer) receives information regarding the tissue region to be ablated and additional factors. Next, the system determines contraction points and computes a contraction region. Next, contraction deformations are computed based upon the determined contraction points and the computed contraction region. Finally, deformations are applied based upon the computed contraction deformations, and a target tissue region adjusting for ablation-related anatomical changes (e.g., tissue contraction) is generated.
In certain embodiments, the system communicates with the energy delivery device or an operator such that the energy delivery device is properly positioned at an identified target tissue region so as to effect an ablation that will ablate the desired tissue, accounting for tissue contraction caused by the ablation process.
In certain embodiments, the present invention provides systems for treating a tissue region within a subject. In some embodiments, such systems comprise a processor as described above (with associated software), and an energy delivery device or devices. In some embodiments, the processor is configured to communicate with the energy delivery device. In some embodiments, the systems further comprise an energy generator in communication with the energy delivery device.
In certain embodiments, the present invention provides systems for the delivery of ablation energy comprising a power supply, delivering power management system (e.g., a power splitter to control power delivery to two or more probes), a processor, an energy emitting device (e.g., ablation probe), a cooling system, an imaging system, a temperature monitoring system, and/or a procedure tracking system.
In certain embodiments, the processor is further configured to quantify and compare the distance and direction difference between a targeted tissue region prior to adjustment for ablation-related anatomical changes and a targeted tissue region prior to adjustment for ablation-related anatomical changes. Similarly, in some embodiments, the processor is configured to quantify and compare the actual distance and direction difference (e.g., prior to ablation procedure and post ablation procedure) between a targeted tissue region not adjusted for ablation-related anatomical changes and a targeted tissue region adjusted for ablation-related anatomical changes.
In certain embodiments, the processor provides information regarding the contraction points to a user (e.g., via a processor based visual display, via wireless communication, etc.). For example, in some embodiments, the tissue region is provided along with the contraction points and the computed contraction point distances and directions for each point during the procedure (e.g., prior, after, and at any point during the procedure). In some embodiments, the minimum and maximum margin distances and directions for the tissue region and each contraction point is provided.
In certain embodiments, the processor is configured to measure the smallest and largest distance between the target tissue region before and after ablation (e.g., ablation after contraction). In some embodiments, such measured distances are used to determine if desired margins are met during and following an ablation procedure.
In certain embodiments, the processor is configured to monitor and/or control and/or provide feedback concerning one or more aspects during the ablation procedure. For example, in some embodiments, the processor is configured to monitor the predicted contraction point distance and/or direction for each contraction point during the ablation procedure. In some embodiments, the processor is configured to stop the ablation procedure if the predicted contraction point distance and/or direction for one or more contraction points is inconsistent with the actual respective contraction point distance and/or direction. In some embodiments, the processor is configured to adjust the amount of energy delivered (e.g., raise or lower) during the ablation procedure if the predicted contraction point distance and/or direction for one or more contraction points is inconsistent with the actual respective contraction point distance and/or direction. In some embodiments, the processor is configured to re-calculate contraction point distances and/or directions for one or more contraction points if the predicted contraction point distance and/or direction for one or more contraction points is inconsistent with the actual respective contraction point distance and/or direction. In some embodiments, the processor is configured to identify new contraction points and/or re-calculate contraction point distances and/or directions for one or more existing contraction points if the predicted contraction point distance and/or direction for one or more contraction points is inconsistent with the actual contraction point distance and/or direction for each contraction point. In some embodiments, processor is configured to make similar adjustments based upon differences in predicted versus actual temperature differences within the tissue region, temperature differences in the energy delivery device, etc.
In certain embodiments, the processor is configured to measure the smallest and largest distance between the target tissue region before and after ablation (e.g., ablation after contraction). In some embodiments, such measured distances are used to determine if desired margins are met during and following an ablation procedure.
The systems of the present invention may be combined within various system/kit embodiments. For example, in some embodiments, systems comprising one or more or all of a computer having a processor, a generator, a power distribution system, and an energy applicator, along with any one or more accessory component (e.g., surgical instruments, temperature monitoring devices, etc.). Exemplary system components are described in
U.S. Pat. Nos. 7,101,369,
9,072,532,
9,119,649, and
9,192,438 and
U.S. Publ. No. 20130116679.
The systems of the present invention may be used in any medical procedure involving delivery of energy (e.g., radiofrequency energy, microwave energy, laser, focused ultrasound, etc.) to a tissue region.
The systems are not limited to treating a particular type or kind of tissue region (e.g., brain, liver, heart, blood vessels, foot, lung, bone, etc.). In some embodiments, the systems find use in ablating tumor regions. Additional treatments include, but are not limited to, treatment of heart arrhythmia, tumor ablation (benign and malignant), control of bleeding during surgery, after trauma, for any other control of bleeding, removal of soft tissue, tissue resection and harvest, treatment of varicose veins, intraluminal tissue ablation (e.g., to treat esophageal pathologies such as Barrett's Esophagus and esophageal adenocarcinoma), treatment of bony tumors, normal bone, and benign bony conditions, intraocular uses, uses in cosmetic surgery, treatment of pathologies of the central nervous system including brain tumors and electrical disturbances, sterilization procedures (e.g., ablation of the fallopian tubes) and cauterization of blood vessels or tissue for any purposes. In some embodiments, the surgical application comprises ablation therapy (e.g., to achieve coagulative necrosis). In some embodiments, the surgical application comprises tumor ablation to target, for example, primary or metastatic tumors. In some embodiments, the surgical application comprises the control of hemorrhage (e.g. electrocautery). In some embodiments, the surgical application comprises tissue cutting or removal.
The energy delivery systems contemplate the use of any type of device configured to deliver (e.g., emit) energy (e.g., ablation device, surgical device, etc.) (see, e.g.,
U.S. Patent Nos. 7,101,369,
7,033,352,
6,893,436,
6,878,147,
6,823,218,
6,817,999,
6,635,055,
6,471,696,
6,383,182,
6,312,427,
6,287,302,
6,277,113,
6,251,128,
6,245,062,
6,026,331,
6,016,811,
5,810,803,
5,800,494,
5,788,692,
5,405,346,
4,494,539,
U.S. Patent Application Serial Nos. 11/728,460,
11/728,457,
11/728,428,
11/237,136,
11/236,985,
10/980,699,
10/961,994,
10/961,761,
10/834,802,
10/370,179,
09/847,181; Great Britain Patent Application Nos.
2,406,521,
2,388,039; European Patent No.
1395190; and International Patent Application Nos.
WO 06/008481,
WO 06/002943,
WO 05/034783,
WO 04/112628,
WO 04/033039,
WO 04/026122,
WO 03/088858,
WO 03/039385WO 95/04385). Such devices include any and all medical, veterinary, and research applications devices configured for energy emission, as well as devices used in agricultural settings, manufacturing settings, mechanical settings, or any other application where energy is to be delivered.
In some embodiments, the energy delivery systems utilize processors that monitor and/or control and/or provide feedback concerning one or more of the components of the system. In some embodiments, the processor is provided within a computer module. For example, in some embodiments, the systems provide software for regulating the amount of microwave energy provided to a tissue region through monitoring one or more characteristics of the tissue region including, but not limited to, the size and shape of a target tissue, the temperature of the tissue region, and the like (e.g., through a feedback system) (see, e.g.,
U.S. Patent Application Serial Nos. 11/728,460,
11/728,457, and
11/728,428). In some embodiments, the software is configured to provide information (e.g., monitoring information) in real time. In some embodiments, the software is configured to interact with the energy delivery systems such that it is able to raise or lower (e.g., tune) the amount of energy delivered to a tissue region. In some embodiments, the software is designed to regulate coolant. In some embodiments, the type of tissue being treated (e.g., liver) is inputted into the software for purposes of allowing the processor to regulate (e.g., tune) the delivery of energy to the tissue region based upon pre-calibrated methods for that particular type of tissue region. In other embodiments, the processor generates a chart or diagram based upon a particular type of tissue region displaying characteristics useful to a user of the system. In some embodiments, the processor provides energy delivering algorithms for purposes of, for example, slowly ramping power to avoid tissue cracking due to rapid out-gassing created by high temperatures. In some embodiments, the processor allows a user to choose power, duration of treatment, different treatment algorithms for different tissue types, simultaneous application of power to the antennas in multiple antenna mode, switched power delivery between antennas, coherent and incoherent phasing, etc. In some embodiments, the processor is configured for the creation of a database of information (e.g., required energy levels, duration of treatment for a tissue region based on particular patient characteristics) pertaining to ablation treatments for a particular tissue region based upon previous treatments with similar or dissimilar patient characteristics. In some embodiments, the processor is operated by remote control.
In some embodiments, user interface software is provided for monitoring and/or operating the components of the energy delivery systems. In some embodiments, the user interface software is operated by a touch screen interface. In some embodiments, the user interface software may be implemented and operated within a sterile setting (e.g., a procedure room) or in a non-sterile setting. In some embodiments, the user interface software is implemented and operated within a procedure device hub (e.g., via a processor). In some embodiments, the user interface software is implemented and operated within a procedure cart (e.g., via a processor). The user interface software is not limited to particular functions. Examples of functions associated with the user interface software include, but are not limited to, tracking the number of uses per component within the energy delivery system (e.g., tracking the number of times an energy delivery device is used), providing and tracking real time temperatures of each component or parts of each component (e.g., providing real time temperature of different locations along an energy delivery device (e.g., at the handle, at the stick, at the tip)) (e.g., providing real time temperature of the cables associated with the energy delivery systems), providing and tracking real time temperature of the tissue being treated, providing an automatic shut off for the part or all of the energy delivery system (e.g., an emergency shut off), generation of reports based upon the data accumulated, for example, prior to, during and after a procedure, providing audible and/or visual alerts to a user (e.g., alerts indicating a procedure has begun and/or is finished, alerts indicating a temperature has reached an aberrant level, alerts indicating the length of the procedure has gone beyond a default, etc.).
In some embodiments, the energy delivery systems utilize imaging systems comprising imaging devices. The energy delivery systems are not limited to particular types of imaging devices (e.g., endoscopic devices, stereotactic computer assisted neurosurgical navigation devices, thermal sensor positioning systems, motion rate sensors, steering wire systems, intraprocedural ultrasound, interstitial ultrasound, microwave imaging, acoustic tomography, dual energy imaging, fluoroscopy, computerized tomography magnetic resonance imaging, nuclear medicine imaging devices triangulation imaging, thermoacoustic imaging, infrared and/or laser imaging, electromagnetic imaging) (see, e.g.,
U.S. Patent Nos. 6,817,976,
6,577,903, and
5,697,949,
5,603,697, and International Patent Application No.
WO 06/005,579). In some embodiments, the systems utilize endoscopic cameras, imaging components, and/or navigation systems that permit or assist in placement, positioning, and/or monitoring of any of the items used with the energy systems of the present invention.
In some embodiments, the energy delivery systems utilize tuning elements for adjusting the amount of energy delivered to the tissue region. In some embodiments, the tuning element is manually adjusted by a user of the system. In some embodiments, a tuning system is incorporated into an energy delivery device so as to permit a user to adjust the energy delivery of the device as desired (see, e.g.,
U.S. Patent Nos. 5,957969,
5,405,346).
In some embodiments, the energy delivery systems utilize coolant systems so as to reduce undesired heating within and along an energy delivery device (e.g., tissue ablation catheter). The systems are not limited to a particular cooling system mechanism.
In some embodiments, the energy delivering systems utilize temperature monitoring systems. In some embodiments, temperature monitoring systems are used to monitor the temperature of an energy delivery device (e.g., with a temperature sensor). In some embodiments, temperature monitoring systems are used to monitor the temperature of a tissue region (e.g., tissue being treated, surrounding tissue). In some embodiments, the temperature monitoring systems are designed to communicate with a processor for purposes of providing temperature information to a user or to the processor to allow the processor to adjust the system appropriately.
The system may further employ one or more additional components that either directly or indirectly take advantage of or assist the features of the present invention. For example, in some embodiments, one or more monitoring devices are used to monitor and/or report the function of any one or more components of the system. Additionally, any medical device or system that might be used, directly or indirectly, in conjunction with the devices of the present invention may be included with the system. Such components include, but are not limited to, sterilization systems, devices, and components, other surgical, diagnostic, or monitoring devices or systems, computer equipment, handbooks, instructions, labels, and guidelines, robotic equipment, and the like.
The systems are not limited to particular uses. Indeed, the energy delivery systems of the present invention are designed for use in any setting wherein the emission of energy is applicable. Such uses include any and all medical, veterinary, and research applications. In addition, the systems and devices of the present invention may be used in agricultural settings, manufacturing settings, mechanical settings, or any other application where energy is to be delivered. In some embodiments, the systems are configured for open surgery, percutaneous, intravascular, intracardiac, endoscopic, intraluminal, laparoscopic, or surgical delivery of energy. In some embodiments, the energy delivery devices may be positioned within a patient's body through a catheter, through a surgically developed opening, and/or through a body orifice (e.g., mouth, ear, nose, eyes, vagina, penis, anus) (e.g., a N.O.T.E.S. procedure). In some embodiments, the systems are configured for delivery of energy to a target tissue or region.
The present invention is not limited by the nature of the target tissue or region. Uses include, but are not limited to, treatment of heart arrhythmia, tumor ablation (benign and malignant), control of bleeding during surgery, after trauma, for any other control of bleeding, removal of soft tissue, tissue resection and harvest, treatment of varicose veins, intraluminal tissue ablation (e.g., to treat esophageal pathologies such as Barrett's Esophagus and esophageal adenocarcinoma), treatment of bony tumors, normal bone, and benign bony conditions, intraocular uses, uses in cosmetic surgery, treatment of pathologies of the central nervous system including brain tumors and electrical disturbances, sterilization procedures (e.g., ablation of the fallopian tubes) and cauterization of blood vessels or tissue for any purposes. In some embodiments, the surgical application comprises ablation therapy (e.g., to achieve coagulative necrosis). In some embodiments, the surgical application comprises tumor ablation to target, for example, metastatic tumors. In some embodiments, the device is configured for movement and positioning, with minimal damage to the tissue or organism, at any desired location, including but not limited to, the brain, neck, chest, abdomen, and pelvis. In some embodiments, the systems are configured for guided delivery, for example, by computerized tomography, ultrasound, magnetic resonance imaging, fluoroscopy, and the like.
A method of treating a tissue region can comprise providing a tissue region and a system described herein (e.g., an energy delivery device, and at least one of the following components: a processor utilizing an algorithm of the present invention, a power supply, a temperature monitor, an imager, a tuning system, and/or a temperature reduction system); identifying and locating a targeted tissue region adjusting for expected ablation-related anatomical changes (e.g., tissue contraction); positioning a portion of the energy delivery device in the vicinity of the tissue region, and delivering an amount of energy with the device to the tissue region. The tissue region may be a tumor. The delivering of the energy may result in, for example, the ablation of the tissue region and/or thrombosis of a blood vessel, and/or electroporation of a tissue region. The tissue region may comprise one or more of the heart, liver, genitalia, stomach, lung, large intestine, small intestine, brain, neck, bone, kidney, muscle, tendon, blood vessel, prostate, bladder, and spinal cord.
Various modifications and variations of the described compositions, methods, and uses of the technology will be apparent to those skilled in the art. Although the technology has been described in connection with specific exemplary embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications of the described modes for carrying out the invention that are obvious to those skilled in the art are intended to be within the scope of the following claims.